RARE(Ultragenyx Pharmaceutical Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-10-15 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 7,066 | $15.27 |
| 2026-09-15 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 公开市场卖出 | 1,283 | $13.57 |
| 2026-09-03 | Huizenga Theodore Alan | SVP, Chief Accounting Officer | 公开市场卖出 | 161 | $13.99 |
| 2026-08-03 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 公开市场卖出 | 1,900 | $24.92 |
| 2026-08-03 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 4,696 | $24.92 |
| 2026-07-01 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 4,698 | $33.13 |
| 2026-06-15 | Sanders Corazon (Corsee) D. | 董事 | 公开市场卖出 | 2,000 | $25.05 |
| 2026-06-15 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 公开市场卖出 | 1,899 | $24.62 |
| 2026-06-01 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 4,653 | $23.77 |
| 2026-05-18 | SULIMAN SHEHNAAZ | 董事 | 公开市场卖出 | 5,740 | $25.12 |
| 2026-05-05 | Crombez Eric | EVP and Chief Medical Officer | 公开市场卖出 | 344 | $24.96 |
| 2026-05-01 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 4,683 | $24.90 |
| 2026-04-01 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 4,683 | $20.97 |
| 2026-03-10 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 公开市场卖出 | 3,508 | $22.67 |
| 2026-03-06 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 公开市场卖出 | 6,018 | $21.40 |
| 2026-03-03 | Horn Howard | Chief Financial Officer | 公开市场卖出 | 1,635 | $22.40 |
| 2026-03-02 | Pinion John Richard | See Remarks | 公开市场卖出 | 10,029 | $22.80 |
| 2026-03-02 | Harris Erik | EVP & Chief Commercial Officer | 公开市场卖出 | 10,539 | $22.80 |
| 2026-03-02 | KAKKIS EMIL D | President & CEO | 公开市场卖出 | 54,404 | $22.80 |
| 2026-03-02 | Parschauer Karah Herdman | EVP and Chief Legal Officer | 公开市场卖出 | 8,135 | $22.80 |